![Eagle Pharmaceuticals, Inc. logo](/logos/EGRX.webp)
Eagle Pharmaceuticals, Inc.
NASDAQ:EGRX
Overview | Financials
Company Name | Eagle Pharmaceuticals, Inc. |
Symbol | EGRX |
Currency | USD |
Price | 4.25 |
Market Cap | 55,194,750 |
Dividend Yield | 0% |
52-week-range | 3.21 - 17.32 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Scott L. Tarriff |
Website | https://www.eagleus.com |
An error occurred while fetching data.
About Eagle Pharmaceuticals, Inc.
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD